Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >Biochemical Engineering >Inhibitors >Autophagy >LRRK2 inhibitors >LRRK2-kinase inhibitor

LRRK2-kinase inhibitor

LRRK2-kinase inhibitor Structure
  • ₹12178.13 - ₹48896.53
  • Product name: LRRK2-kinase inhibitor
  • CAS: 1285515-21-0
  • MF: C24H18FN3O2
  • MW: 399.42
  • EINECS:
  • MDL Number:MFCD22665702
  • Synonyms:LRRK2-kinase inhibitor;GSK2578215A, >=98%;2-(benzyloxy)-5-(2-fluoropyridin-4-yl)-N-(pyridin-3-yl)benzaMide;5-(2-Fluoro-4-pyridinyl)-2-(phenylmethoxy)-N-3-pyridinylbenzamide GSK2578215A;5-(2-fluoro-4-pyridinyl)-2-[(phenylmethyl)oxy]-N-3-pyridinylbenzamide;GSK2578125A;BenzaMide, 5-(2-fluoro-4-pyridinyl)-2-(phenylMethoxy)-N-3-pyridinyl-;GSK2578215A
2 prices
Selected condition:

Brand

  • Sigma-Aldrich(India)

Package

  • 5MG
  • 25MG
  • ManufacturerSigma-Aldrich(India)
  • Product numberSML0660
  • Product descriptionGSK2578215A ≥98% (HPLC)
  • Packaging5MG
  • Price₹12178.13
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberSML0660
  • Product descriptionGSK2578215A ≥98% (HPLC)
  • Packaging25MG
  • Price₹48896.53
  • Updated2022-06-14
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Sigma-Aldrich(India) SML0660 GSK2578215A ≥98% (HPLC) 5MG ₹12178.13 2022-06-14 Buy
Sigma-Aldrich(India) SML0660 GSK2578215A ≥98% (HPLC) 25MG ₹48896.53 2022-06-14 Buy

Properties

Boiling point :556.1±50.0 °C(Predicted)
Density :1.292±0.06 g/cm3(Predicted)
storage temp. :2-8°C
solubility :DMSO: soluble15mg/mL, clear
form :powder
pka :12.31±0.70(Predicted)
color :white to beige

Safety Information

Symbol(GHS):
Signal word:
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:

Description

GSK2578215A is a potent, selective LRRK2 inhibitor and a promising therapeutic for treating Parkinson''s disease.